Cisplatin-Induced Hearing Loss in Mice
Corresponding Organization :
Other organizations : University of Florida, University at Buffalo, State University of New York, Barrow Neurological Institute, University of St. Augustine for Health Sciences, Whitney Museum of American Art, The University of Tokyo, Asia University
Variable analysis
- Cisplatin administration (100 mg/ml; APP pharmaceuticals) at 3 mg/kg each day for 4 days, repeated for a total of two cycles
- Auditory Brainstem Response (ABR) tests performed 1 week before the first cisplatin injection and after the final cisplatin injection
- Saline (2-3 ml; Teknova, Fishersci) administered 1 day before the first cisplatin injection, during the 4-day cisplatin injection period, and during the 10-day recovery period
- High calorie liquid diet (STAT, PRN Pharmacal) and bacon softies (BioServ) provided daily
- Mice housed in cages with mouse Igloos (hut) with attached wheel (BioServ) throughout the cisplatin administration protocol
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!